Canandaigua National Bank & Trust Co. decreased its stake in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) by 1.4% during the second quarter, Holdings Channel reports. The fund owned 1,745 shares of the company’s stock after selling 25 shares during the period. Canandaigua National Bank & Trust Co.’s holdings in Intuitive Surgical were worth $1,154,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Institutional Trust Company N.A. boosted its position in Intuitive Surgical by 2.4% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 960,021 shares of the company’s stock valued at $577,021,000 after buying an additional 22,158 shares during the last quarter. BlackRock Fund Advisors boosted its position in Intuitive Surgical by 0.3% in the first quarter. BlackRock Fund Advisors now owns 669,181 shares of the company’s stock valued at $402,211,000 after buying an additional 1,922 shares during the last quarter. TIAA CREF Investment Management LLC raised its position in Intuitive Surgical by 29.5% in the first quarter. TIAA CREF Investment Management LLC now owns 520,997 shares of the company’s stock valued at $313,145,000 after buying an additional 118,738 shares during the period. JPMorgan Chase & Co. raised its position in Intuitive Surgical by 643.9% in the first quarter. JPMorgan Chase & Co. now owns 329,830 shares of the company’s stock valued at $198,243,000 after buying an additional 285,490 shares during the period. Finally, Geode Capital Management LLC raised its position in Intuitive Surgical by 2.9% in the first quarter. Geode Capital Management LLC now owns 313,692 shares of the company’s stock valued at $188,175,000 after buying an additional 8,828 shares during the period. 92.28% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Inc. (NASDAQ:ISRG) traded up 0.77% during mid-day trading on Tuesday, hitting $698.87. 281,016 shares of the company traded hands. The company has a market capitalization of $26.90 billion, a price-to-earnings ratio of 39.66 and a beta of 0.73. The company’s 50-day moving average price is $688.34 and its 200 day moving average price is $647.09. Intuitive Surgical Inc. has a one year low of $447.00 and a one year high of $720.01.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 19th. The company reported $5.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.97 by $0.65. The firm earned $670 million during the quarter, compared to analysts’ expectations of $640.69 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. During the same period in the previous year, the business posted $4.57 EPS. On average, analysts anticipate that Intuitive Surgical Inc. will post $21.30 earnings per share for the current fiscal year.

Several research firms have recently weighed in on ISRG. Piper Jaffray Cos. restated a “neutral” rating and set a $700.00 price objective (up previously from $610.00) on shares of Intuitive Surgical in a research report on Wednesday, July 20th. Bank of America Corp. restated a “buy” rating on shares of Intuitive Surgical in a research report on Monday, June 6th. Barclays PLC raised their price objective on shares of Intuitive Surgical from $690.00 to $750.00 and gave the company an “overweight” rating in a research report on Wednesday, July 20th. Zacks Investment Research lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Monday, June 27th. Finally, Canaccord Genuity restated a “buy” rating and set a $700.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, June 7th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $701.42.

In other Intuitive Surgical news, SVP Mark J. Meltzer sold 3,000 shares of the business’s stock in a transaction dated Monday, August 22nd. The stock was sold at an average price of $688.33, for a total transaction of $2,064,990.00. Following the completion of the sale, the senior vice president now directly owns 2,331 shares of the company’s stock, valued at approximately $1,604,497.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 13,400 shares of the business’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $698.00, for a total value of $9,353,200.00. Following the sale, the chief executive officer now directly owns 78,780 shares of the company’s stock, valued at $54,988,440. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical Inc. (NASDAQ:ISRG).

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.